Clinicogenomic landscape and outcomes of metastatic colorectal cancer patients with pathogenic GNAS variants. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

HIPEC combined with camrelizumab, paclitaxel and S-1 for conversion therapy in patients with advanced gastric cancer with peritoneal metastasis: A prospective phase II clinical study. This is an ASCO ...

1Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. *Corresponding Author: M.H. Chui, Department of Pathology and Laboratory Medicine, ...

Read at the clinicopathological conference at the Massachusetts General Hospital on May 11, 1939.

Patients with eosinophilic esophagitis face significant economic burdens, according to a pair of presentations at Digestive ...

Study results show that DecisionDx-Melanoma was associated with a 32% reduction in mortality risk compared to untested ...

4), suggesting limited utility of this marker in risk stratification for recurrence when other clinicopathologic factors are considered. Cipriani emphasized that while BRAF immunostaining is a useful ...

Recurrent lupus nephritis pathology in the kidney transplant may not appear the same as previous disease in the native kidney.